Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
3.828
-0.162 (-4.05%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Advanced Biomed Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-2.28-2.78-3.73-4.03-1.84
Depreciation & Amortization
0.280.270.230.110.06
Other Amortization
0.130.130.140.01-
Loss (Gain) From Sale of Assets
--0.150.04-
Asset Writedown & Restructuring Costs
---1.62-
Change in Accounts Payable
0.560.480.380.910.02
Change in Other Net Operating Assets
-0.23-0.22-0.130.591.29
Operating Cash Flow
-1.54-2.13-2.96-0.74-0.47
Capital Expenditures
-0.09-0.07-0.21-0.89-0.03
Sale of Property, Plant & Equipment
---0.03-
Cash Acquisitions
---0.2-
Divestitures
---0.05--
Sale (Purchase) of Intangibles
---0-0.42-
Investing Cash Flow
-0.09-0.07-0.26-1.08-0.03
Long-Term Debt Issued
-1.66---
Net Debt Issued (Repaid)
1.751.66---
Issuance of Common Stock
--1.016.10.7
Other Financing Activities
0.190.21-0.55--
Financing Cash Flow
1.951.870.466.10.7
Foreign Exchange Rate Adjustments
-0.260.320.610.45-0.2
Net Cash Flow
0.06-0.01-2.164.720
Free Cash Flow
-1.63-2.2-3.17-1.63-0.5
Free Cash Flow Per Share
-0.08-0.11-0.16-0.12-0.04
Levered Free Cash Flow
-3.02-1.93-1.40.69-
Unlevered Free Cash Flow
-3.02-1.93-1.40.69-
Change in Net Working Capital
1.70.67-0.36-3.36-
Updated Jan 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q